000 02126 a2200553 4500
005 20250514024314.0
264 0 _c20020328
008 200203s 0 0 eng d
022 _a0022-3565
024 7 _a10.1124/jpet.300.3.1093
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHansen, J Paul
245 0 0 _aMethylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cMar 2002
300 _a1093-100 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBiological Transport
_xdrug effects
650 0 4 _aBody Temperature
_xdrug effects
650 0 4 _aCell Membrane
_xdrug effects
650 0 4 _aCocaine
_xanalogs & derivatives
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aDopamine Plasma Membrane Transport Proteins
650 0 4 _aDopamine Uptake Inhibitors
_xtoxicity
650 0 4 _aHallucinogens
_xtoxicity
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aMembrane Glycoproteins
_xbiosynthesis
650 0 4 _aMembrane Transport Proteins
_xbiosynthesis
650 0 4 _aMethamphetamine
_xtoxicity
650 0 4 _aN-Methyl-3,4-methylenedioxyamphetamine
_xtoxicity
650 0 4 _aNerve Tissue Proteins
650 0 4 _aNeuropeptides
650 0 4 _aNeurotoxins
_xtoxicity
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSynaptic Vesicles
_xdrug effects
650 0 4 _aTetrabenazine
_xanalogs & derivatives
650 0 4 _aVesicular Biogenic Amine Transport Proteins
650 0 4 _aVesicular Monoamine Transport Proteins
700 1 _aRiddle, Evan L
700 1 _aSandoval, VerĂ³nica
700 1 _aBrown, Jeffrey M
700 1 _aGibb, James W
700 1 _aHanson, Glen R
700 1 _aFleckenstein, Annette E
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 300
_gno. 3
_gp. 1093-100
856 4 0 _uhttps://doi.org/10.1124/jpet.300.3.1093
_zAvailable from publisher's website
999 _c11769683
_d11769683